A Study on the Efficacy of the Metaverse Lifestyle Health Education Model Based on the Transtheoretical Model for Improving Quality of Life and Modifying Lifestyle in Colorectal Cancer Survivors

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorQu Shen

About this trial

Colorectal cancer is a globally prevalent malignant tumor. Postoperative patients often face physical discomfort, psychological stress, and lack of healthy lifestyles. However, traditional health education models have limitations such as insufficient targeting and poor interactivity, making it difficult to meet their needs for full-cycle health management. This study is a multicenter randomized controlled trial, which plans to enroll 174 patients aged 18 years and above who have undergone radical resection for colorectal cancer, and randomly divide them into an experimental group and a control group at a ratio of 1:1. The experimental group will receive Transtheoretical Model (TTM)-based metaverse lifestyle health education (including phased course learning, metaverse immersive interaction, and WeChat group check-in supervision) with an intervention cycle of 1 months and follow-up until 3 months after the intervention; the control group will only receive routine paper-based education and outpatient follow-up. The study aims to verify the improvement effect of this metaverse intervention model on the quality of life and healthy lifestyle of colorectal cancer survivors, and explore its role in improving patients' self-efficacy, so as to provide empirical evidence for optimizing long-term health management programs for cancer survivors.

Eligibility criteria

Qualifiers

Patients with first diagnosed colorectal cancer who have undergone radical surgical treatment

Aged ≥18 years old and non-pregnant

Have basic communication, reading and comprehension abilities, and can proficiently use smartphones and WeChat

Voluntarily sign the informed consent form and promise to cooperate in completing all interventions and follow-up assessments

Disqualifiers

Patients with other types of malignant tumors

Patients with incompletely resected tumors or distant metastases

Patients with dysfunction of important organs such as heart, liver and kidney, or with unstable/rapidly deteriorating conditions

Patients with severe cognitive impairment who cannot communicate normally and cooperate with the intervention

Trial design

Treatments tested in this trial

  • TTM-Based Metaverse Lifestyle Health Education

Treatment groups

174 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Qu Shen

Lead sponsor

Xiamen University

Sponsor institution